Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (64)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Gammon, M. D.
Right arrow Articles by Thompson, W. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gammon, M. D.
Right arrow Articles by Thompson, W. D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 134, No. 8: 818-824
Copyright © 1991 by The Johns Hopkins University School of Hygiene and Public Health

research-article

Polycystic Ovaries and the Risk of Breast Cancer

Marilie D. Gammon1 and W. Douglas Thompson2

1Division of Epidemiology, Columbia University School of Public Health New York, NY
2Department of Applied Medical Sciences, University of Southern Maine Portland, ME

Data from a case-control study that was conducted between 1980 and 1982 were analyzed to investigate the possible association between polycystic ovaries and the risk of breast cancer. The multicenter, population-based study included in-home interviews with 4,730 women with breast cancer and 4, 688 control women aged 20–54 years. The age-adjusted odds ratio for breast cancer among women with a self-reported history of physician-diagnosed polycystic ovaries was 0.52 (95% confidence interval 0.32–0.87). The inverse association was not an artifact of infertility, age at first birth, or surgical menopause. Because women with this syndrome have abnormal levels of certain endogenous hormones, the observation of a low risk of breast cancer in this group may provide new insights into hormonal influences on breast cancer.

breast neoplasms; polycystic ovary syndrome


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Menopause IntHome page
C. L Shufelt and G. D Braunstein
Testosterone and the breast
Menopause Int, September 1, 2008; 14(3): 117 - 122.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. E. Wierman, R. Basson, S. R. Davis, S. Khosla, K. K. Miller, W. Rosner, and N. Santoro
Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline
J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3697 - 3710.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
K. L. Terry, W. C. Willett, J. W. Rich-Edwards, D. J. Hunter, and K. B. Michels
Menstrual Cycle Characteristics and Incidence of Premenopausal Breast Cancer
Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1509 - 1513.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
L. A. Brinton, B. Scoccia, K. S. Moghissi, C. L. Westhoff, M. D. Althuis, J. E. Mabie, and E. J. Lamb
Breast cancer risk associated with ovulation-stimulating drugs
Hum. Reprod., September 1, 2004; 19(9): 2005 - 2013.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
E. Weiderpass, T. Braaten, C. Magnusson, M. Kumle, H. Vainio, E. Lund, and H.-O. Adami
A Prospective Study of Body Size in Different Periods of Life and Risk of Premenopausal Breast Cancer
Cancer Epidemiol. Biomarkers Prev., July 1, 2004; 13(7): 1121 - 1127.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
W. Somboonporn and S. R. Davis
Testosterone Effects on the Breast: Implications for Testosterone Therapy for Women
Endocr. Rev., June 1, 2004; 25(3): 374 - 388.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Gonzalez, E. Abril, A. Roca, M. J. Aragon, M. J. Figueroa, P. Velarde, R. Ruiz, O. Fayez, J. J. Galan, J. A. Herreros, et al.
Specific CAPN10 Gene Haplotypes Influence the Clinical Profile of Polycystic Ovary Patients
J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5529 - 5536.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
V. De Leo, A. la Marca, and F. Petraglia
Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome
Endocr. Rev., October 1, 2003; 24(5): 633 - 667.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.